Meaning of tumor protein 53-induced nuclear protein 1 in the molecular mechanism of gemcitabine sensitivity.

Nakaya, Naoki; Ishigaki, Yasuhito; Nakajima, Hideo; Murakami, Manabu; Shimasaki, Takeo; Takata, Takanobu; Ozaki, Mamoru; Dusetti, Nelson J; Iovanna, Juan L; Motoo, Yoshiharu

Nakaya, Naoki; Ishigaki, Yasuhito; Nakajima, Hideo; Murakami, Manabu; Shimasaki, Takeo; Takata, Takanobu; Ozaki, Mamoru; Dusetti, Nelson J; Iovanna, Juan L; Motoo, Yoshiharu.

Afiliação

Nakaya N; Department of Medical Oncology.
Ishigaki Y; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa;
Nakajima H; Department of Medical Oncology ; Department of Oncology, Ageo Central General Hospital, Ageo, Saitama, Japan;
Murakami M; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa;
Shimasaki T; Department of Medical Oncology.
Takata T; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa;
Ozaki M; Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa;
Dusetti NJ; Stress Cellulaire, INSERM U624, Marseille, France.
Iovanna JL; Stress Cellulaire, INSERM U624, Marseille, France.
Motoo Y; Department of Medical Oncology.

Mol Clin Oncol ; 1(1): 100-104, 2013 Jan.

Article em En | MEDLINE | ID: mdl-24649130

Palavras-chave

cell cycle; gemcitabine; p21; p53; tumor protein 53-induced nuclear protein 1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2013 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google